{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:26:38Z","timestamp":1779229598757,"version":"3.51.4"},"reference-count":40,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2015,3,18]]},"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To conduct a fully independent, external validation of a research study based on one electronic health record database using a different database sampling from the same population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort analysis of \u03b2-blocker therapy and all-cause mortality in patients with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two UK national primary care databases (PCDs): the Clinical Practice Research Datalink (CPRD) and Doctors\u2019 Independent Network (DIN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>CPRD data for 11\u2005302 patients with cancer compared with published results from DIN for 3462 patients; study period January 1997 to December 2006.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>All-cause mortality: overall; by treatment subgroup (\u03b2-blockers only, \u03b2-blockers plus other blood pressure lowering medicines (BPLM), other BPLMs only); and by cancer site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using CPRD, \u03b2-blocker use was not associated with mortality (HR=1.03, 95% CI 0.93 to 1.14, vs patients prescribed other BPLMs only), but DIN \u03b2-blocker users had significantly higher mortality (HR=1.18, 95% CI 1.04 to 1.33). However, these HRs were not statistically different (p=0.063), but did differ for patients on \u03b2-blockers alone (CPRD=0.94, 95% CI 0.82 to 1.07; DIN=1.37, 95% CI 1.16 to 1.61; p&lt;0.001). Results for individual cancer sites differed by study, but only significantly for prostate and pancreas cancers. Results were robust under sensitivity analyses, but we could not be certain that mortality was identically defined in both databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found a complex pattern of similarities and differences between databases. Overall treatment effect estimates were not statistically different, adding to a growing body of evidence that different UK PCDs produce comparable effect estimates. However, individually the two studies lead to different conclusions regarding the safety of \u03b2-blockers and some subgroup effects differed significantly. Single studies using even internally well-validated databases do not guarantee generalisable results, especially for subgroups, and confirmatory studies using at least one other independent data source are strongly recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2014-007299","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T15:13:30Z","timestamp":1429110810000},"page":"e007299","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Can analyses of electronic patient records be independently and externally validated? Study 2\u2014the effect of \u03b2-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study"],"prefix":"10.1136","volume":"5","author":[{"given":"David A","family":"Springate","sequence":"first","affiliation":[{"name":"NIHR School for Primary Care Research, Centre for Primary Care, Institute of Population, Health, University of Manchester, Manchester, UK"},{"name":"Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren M","family":"Ashcroft","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology and Drug Safety, Manchester Pharmacy School, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Kontopantelis","sequence":"additional","affiliation":[{"name":"NIHR School for Primary Care Research, Centre for Primary Care, Institute of Population, Health, University of Manchester, Manchester, UK"},{"name":"Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Doran","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Ryan","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Sciences, School of Health and Population Sciences, University of Birmingham, Edgbaston, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reeves","sequence":"additional","affiliation":[{"name":"NIHR School for Primary Care Research, Centre for Primary Care, Institute of Population, Health, University of Manchester, Manchester, UK"},{"name":"Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"2025102702543403000_5.4.e007299.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004952"},{"key":"2025102702543403000_5.4.e007299.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"2025102702543403000_5.4.e007299.3","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the General Practice Research Database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"BJGP"},{"key":"2025102702543403000_5.4.e007299.4","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmh409"},{"key":"2025102702543403000_5.4.e007299.5","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1934"},{"key":"2025102702543403000_5.4.e007299.6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-7-38"},{"key":"2025102702543403000_5.4.e007299.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2442"},{"key":"2025102702543403000_5.4.e007299.8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt010"},{"key":"2025102702543403000_5.4.e007299.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.015"},{"key":"2025102702543403000_5.4.e007299.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f880"},{"key":"2025102702543403000_5.4.e007299.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304738"},{"key":"2025102702543403000_5.4.e007299.12","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/art.34433","article-title":"Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study","volume":"64","author":"Valkhoff","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025102702543403000_5.4.e007299.13","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.vaccine.2011.06.009","article-title":"A collaborative approach to investigating the risk of thrombocytopenic purpura after measles\u2013mumps\u2013rubella vaccination in England and Denmark","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"2025102702543403000_5.4.e007299.14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/pds.3712","article-title":"Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems","volume":"23","author":"Bell","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025102702543403000_5.4.e007299.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2003.01794.x"},{"key":"2025102702543403000_5.4.e007299.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02697.x"},{"key":"2025102702543403000_5.4.e007299.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f114"},{"key":"2025102702543403000_5.4.e007299.18","unstructured":"Clinical Practice Research Datalink (CPRD). http:\/\/www.cprd.com\/home (accessed 20 Mar 2014)."},{"key":"2025102702543403000_5.4.e007299.19","unstructured":"QResearch. http:\/\/www.qresearch.org (accessed 20 Mar 2014)."},{"key":"2025102702543403000_5.4.e007299.20","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.061523"},{"key":"2025102702543403000_5.4.e007299.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2004.02.002"},{"key":"2025102702543403000_5.4.e007299.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03980.x"},{"key":"2025102702543403000_5.4.e007299.23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-4-14"},{"key":"2025102702543403000_5.4.e007299.24","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.4.417"},{"key":"2025102702543403000_5.4.e007299.25","first-page":"21","article-title":"A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases","volume":"22","author":"De Wilde","year":"2004","journal-title":"Health Stat Q"},{"key":"2025102702543403000_5.4.e007299.26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4289"},{"key":"2025102702543403000_5.4.e007299.27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt196"},{"key":"2025102702543403000_5.4.e007299.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1505-3"},{"key":"2025102702543403000_5.4.e007299.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.4441"},{"key":"2025102702543403000_5.4.e007299.30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.25351","article-title":"Norepinephrine antagonists and cancer risk","volume":"128","author":"Friedman","year":"2011","journal-title":"Int J Cancer"},{"key":"2025102702543403000_5.4.e007299.31","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26727"},{"key":"2025102702543403000_5.4.e007299.32","doi-asserted-by":"publisher","DOI":"10.1177\/1758834012439738"},{"key":"2025102702543403000_5.4.e007299.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099825"},{"key":"2025102702543403000_5.4.e007299.34","unstructured":"http:\/\/data.gov.uk\/dataset\/imd_2004 (accessed 20 Oct 2014)."},{"key":"2025102702543403000_5.4.e007299.35","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16"},{"key":"2025102702543403000_5.4.e007299.36","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2013. http:\/\/R-project.org (accessed 20 Nov 2014)."},{"key":"2025102702543403000_5.4.e007299.37","doi-asserted-by":"crossref","unstructured":"Speed TP . Iterative proportional fitting. Encyclopedia of Biostatistics 4. 2005 . doi:10.1002\/0470011815.b2a10027 doi:10.1002\/0470011815.b2a10027","DOI":"10.1002\/0470011815.b2a10027"},{"key":"2025102702543403000_5.4.e007299.38","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt381"},{"key":"2025102702543403000_5.4.e007299.39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canep.2014.03.011","article-title":"Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK Clinical Practice Research Datalink cohort","volume":"38","author":"Cardwell","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"2025102702543403000_5.4.e007299.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003190"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2014-007299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:54:48Z","timestamp":1761558888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2014-007299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,13]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1136\/bmjopen-2014-007299"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2014-007299","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}